Market Research Report: Apneal
Company Overview
Name
Apneal
Mission of the Company
Apneal aims to transform smartphones into medical devices to provide accessible sleep apnoea diagnosis without the need for supplementary equipment.
Founded
Founded in early 2021.
Founders
- Séverin Benizri: CEO and digital entrepreneur with experience in creating successful services for healthcare professionals and the pharmaceutical industry.
- Guillaume Cathelain: CTO and signal processing and AI researcher, known for developing patented vital sign detection technologies during his PhD work.
Key People
- Séverin Benizri: CEO
- Guillaume Cathelain: CTO
Advisory and Leadership Team:
- Bruno Sicre: Director of Product Marketing, EMEA at Resmed
- Pierre Fertout: Global Sales Ops Director at CoachHub
- Bruno Martinaud: Programme Director, Polytechnique / Berkeley
- Pierre-Emmanuel Cailleux: MD, Geriatrician at Louis Mourier Hospital, AP-HP
- Josselin Houenou: MD, Psychiatry Professor at Henri Mondor Hospital, NeuroSpin Lab, CEA Saclay
- Bruno Rostand: Director of Innovation and Entrepreneurship at University PSL
- François Jouen: Dean of Life Sciences, EPHE – PSL
- Raphaël Hadjedj: ENT Surgeon
- Jean Bergounioux: MD, Pediatric Intensive Care Professor at Raymond Poincaré Hospital
- Pierre A. Geoffroy: MD, Sleep Medicine Professor, Chair of National College of Sleep Medicine Teachers (CNESom), Head of ChronoS Center
- Emilie Bequignon: MD, PU-PH ENT, Chair of French Sleep Association in ENT
Headquarters
No information is available.
Number of Employees
No information is available.
Revenue
No information is available.
Known For
The company is renowned for its innovative solution that utilizes smartphones, enabling users to self-diagnose sleep apnoea without waiting for traditional clinical diagnostics.
Products
Overview
Apneal offers a novel smartphone-based medical-grade application designed to screen for Obstructive Sleep Apnoea Syndrome (OSA).
Product Description
Apneal transforms common smartphones into diagnostic tools for detecting sleep apnoea using a combination of in-built sensors — microphones, accelerometers, and gyroscopes.
High-level Description
The application allows users to conduct sleep examinations without additional equipment by securely positioning the smartphone on their thorax during sleep. The app then utilizes built-in sensors to track respiratory and physical movements, analyzed through AI algorithms to detect any sleep apnoea events.
Key Features
- Fiability: Provides reliability equivalent to at-home ventilatory polygraphy.
- Interpretability: Allows for verification of physiological events throughout the recorded epochs.
- No External Devices: Compatible with over 90% of smartphones.
- Rapid Results: Instant analysis with no waiting time.
- Telemedicine Integration: Well-suited for remote diagnostics.
- AI-Powered Analysis: Utilizes deep learning for signal analysis, equivalent to clinical-grade diagnostics.
Recent Developments
New Products
No information is available on new product launches.
New Features
No information is available on new feature additions.
Partnerships
In 2024, Apneal remains active with multiple partnerships and validation studies across European healthcare institutions, supported by significant funding from EIT Health Flagships.
Ongoing Projects
Apneal is engaged in a multi-site European clinical validation study comparing their app results with traditional polysomnography at centers in France, Germany, and Spain, anticipated to substantiate reliability by mid-2025. The app aims for CE certification as a Class IIa medical device.
Awards and Recognitions
- Won the EIT Health Flagship call for projects
- i-Lab 2023 contest winner
- Awarded the first innovation prize at the Congress of Encéphale 2022
- Data and AI Trophy at Medintechs 2022
This report outlines Apneal's commitment to making sleep apnoea diagnosis more accessible and integrated within regular healthcare practices, leveraging everyday technology in the form of common smartphones.
